cerca CERCA
Giovedì 07 Luglio 2022
Aggiornato: 16:32
Temi caldi

CHIMICA E FARMACEUTICA

comunicato stampa

Novavax Nuvaxovid™ COVID-19 Vaccine Conditionally Authorized in the European Union for Adolescents Aged 12 Through 17

GAITHERSBURG, Md., July 5, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that the European Commission (EC) has approved the expanded conditional marketing authorization (CMA) of Nuvaxovid™ (NVX-CoV2373) COVID-19 vaccine in the European Union (EU) for adolescents aged 12 through 17. The approval follows the positive recommendation made by the European M...

comunicato stampa

Seegene develops PCR test to detect monkeypox virus

SEOUL, South Korea, June 28, 2022 /PRNewswire/ -- Seegene Inc. (KQ965390), South Korea's leading molecular diagnostics (MDx) company has developed a PCR test to detect the monkeypox virus. The Novaplex™ MPXV Assay, which specifically targets the monkeypox virus, was swiftly developed using the company's AI-based automated test development system, known as SGDDS (Seegene Digitalized Development System), and technologies refined over 20 years of MDx expertise.

alternate text

Steriline, eccellenza italiana nella lotta al Covid

Como, 16/06/2022 - I macchinari Steriline simboleggiano il contributo apportato dall’industria italiana alla lotta contro il Covid, con specifico riferimento ai processi di distribuzione e di somministrazione dei vaccini nel mondo. I sofisticatissimi sistemi di riempimento per farmaci iniettabili progettati e prodotti dalla nota azienda comasca, hanno infatti contribuito attivamente all’applicazione delle campagne vaccinali su scala internazionale.

comunicato stampa

FDA Advisory Committee Recommends Emergency Use Authorization of Novavax COVID-19 Vaccine for People Aged 18 Years and Older

GAITHERSBURG, Md., June 7, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced the U.S. Food and Drug Administration (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted 21 to 0, with one abstention, to recommend that the FDA grant Emergency Use Authorization (EUA) for the Novavax COVID-19 vaccine (NVX-CoV2373) for individuals age...

comunicato stampa

Ascend completes purchase of plant in Chennai

HOUSTON, June 1, 2022 /PRNewswire/ -- Ascend Performance Materials has completed its purchase of Formulated Polymers Limited, an engineered materials producer based in Chennai, India. The acquisition establishes Ascend's first production facility in South Asia.

comunicato stampa

MedAlliance's SELUTION SLR drug-eluting balloon (DEB) receives FDA investigational device exemption (IDE) approval, making it the first limus DEB to be available to US patients

GENEVA, May 30, 2022 /PRNewswire/ -- The SELUTION SLR (Sustained Limus Release) is a novel sirolimus-eluting balloon that provides a controlled sustained drug release, similar to a drug-eluting stent (DES). SELUTION SLR was also the first DEB (Drug Eluting Balloon) granted "breakthrough device designation" by the FDA on March 4, 2019 and further in September 25, 2019 for below-the-knee (BTK) indications in peripheral artery disease.

ora in
Prima pagina
Tag più usati
in questa pagina

advanced hepatocellular

advanced hepatocellular carcinoma

biosimilari

bostik

bostik finalizes

carcinoma

chimica_e_farmacia architettura_e_edilizia altro economia_e_finanza

chimica_e_farmacia salute_e_benessere chimica_e_farmacia salute_e_benessere altro

company

conditionally authorized

articoli
in Evidenza